by Zachary | Jan 23, 2025 | Emerging Trends
Raymond A. Lorenz, PharmD, BCPP & Zachary S. Brooks, PhD Pharmacogenomics in Chronic Kidney Disease. What do the genetics of a patient with chronic kidney disease (CKD) have to do with which medications they may respond to? As it turns out, quite a lot! Patients...
by Zachary | Jan 18, 2025 | Emerging Trends
Ezra Smith, PhD & Zachary Brooks, PhD How Pharmacogenomics Reshapes Mental Health. How does the study of genes affect our understanding of medications? By analyzing genes, scientists and clinicians alike more precisely understand drug interactions with the body....
by Zachary | Jan 8, 2025 | Emerging Trends
Jayden Lee, PharmD & Zachary S. Brooks, PhD A New Way to Get Medications: Next Generation Sequencing for You. How do you currently get your medications? You see a doctor who diagnoses you, then receive a prescription. Your pharmacist performs a second check to...
by Zachary | Dec 30, 2024 | Emerging Trends
Jayden Lee, EMBA, PharmD, BCACP & Husna Rahim, PharmD Pharmacogenomics: Effective and reliable Clinical Trials for Depression. With mental health taking center stage post-COVID-19 pandemic, what are some new ways to improve the treatment of depression? One...
by Zachary | Dec 30, 2024 | Emerging Trends
Jayden Lee, EMBA, PharmD, BCACP & Husna Rahim, PharmD The Transformative Potential of Phenoconversion in Pharmacogenomics. What is phenoconversion, and why is it pivotal in the realm of pharmacogenomics (PGx)? An exploration of phenoconversion, PGx mechanisms, and...
by Zachary | Dec 29, 2024 | Emerging Trends
Husna Rahim, PharmD & Jennifer Tovar, PharmD Pharmacogenomics in Cardiovascular Diseases – Making Your Treatment Better. What is the current role of precision medicine in treating cardiovascular diseases (CVDs)? The rapidly evolving field of pharmacology and...
